ExodusPoint Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Sell |
61,684
-87,009
| -59% | -$463K | ﹤0.01% | 1164 |
|
|
2025
Q1 | $1.32M | Buy |
+148,693
| New | +$1.32M | 0.01% | 791 |
|
|
2024
Q3 | – | Sell |
-170,287
| Closed | -$4.17M | – | 1789 |
|
|
2024
Q2 | $4.17M | Buy |
170,287
+91,221
| +115% | +$2.23M | 0.03% | 425 |
|
|
2024
Q1 | $1.69M | Buy |
+79,066
| New | +$1.69M | 0.01% | 666 |
|
|
2023
Q4 | – | Sell |
-17,960
| Closed | -$288K | – | 1775 |
|
|
2023
Q3 | $288K | Sell |
17,960
-343,657
| -95% | -$5.51M | ﹤0.01% | 1385 |
|
|
2023
Q2 | $8.38M | Buy |
+361,617
| New | +$8.38M | 0.07% | 253 |
|
|
2023
Q1 | – | Sell |
-12,300
| Closed | -$178K | – | 1902 |
|
|
2022
Q4 | $178K | Buy |
+12,300
| New | +$178K | ﹤0.01% | 1421 |
|
|
2021
Q1 | – | Sell |
-23,437
| Closed | -$463K | – | 2364 |
|
|
2020
Q4 | $463K | Buy |
+23,437
| New | +$463K | ﹤0.01% | 1230 |
|
|
2020
Q3 | – | Sell |
-36,839
| Closed | -$418K | – | 1998 |
|
|
2020
Q2 | $418K | Buy |
+36,839
| New | +$418K | 0.01% | 1143 |
|